Research Focus

Former Employee. Molecular Pharmacology Program; Non-Stipend SKI

Recent additions – View all

1. Characterization of RNA binding by mutant variants of human dihydrofolate reductase

   Meeting Abstract

   McPherson, J. P.; Sauerbrey, A.; Meehl, M.; Russo, A.; Skacel, N.; Bertino, J. R.
   Proceedings of the American Association for Cancer Research Annual Meeting (1999)

   Fulltext@MSK | Save
2. Expression of a novel double-mutant dihydrofolate reductase-cytidine deaminase fusion gene confers resistance to both methotrexate and cytosine arabinoside

   Journal Article

   Sauerbrey, A.; McPherson, J. P.; Zhao, S. C.; Banerjee, D.; Bertino, J. R.
   Human Gene Therapy (1999)

   Fulltext@MSK | Save
3. Simultaneous resistance to methotrexate (MTX) and cytarabine conferred by expression of a double-mutant dihydrofolate reductase (DHFR)-cytidine deaminase (CD) fusion gene

   Meeting Abstract

   Sauerbrey, A.; McPherson, J. P.; Banerjee, D.; Bertino, J. R.
   Blood (1998)

   Fulltext@MSK | Save